MICROSCLEROTHERAPY TREATMENT MARKET ANALYSIS

Microsclerotherapy Treatment Market, By Product Type (Sclerosant (Detergent-based (Sodium Tetradecyl Sulphate and Ethanolamine Oleate)), Chemical-Based (Chromated Glycerin), Osmotic Agents (Hypertonic Saline or Hypertonic Glucose), Needles, (Others), By End Users (Hospitals, Aesthetic Treatment Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI3372
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Global Microsclerotherapy Treatment Market Regional Analysis-

Highest incidences of telangiectasia has been recorded in the Western Countries like Europe, America and Australia and this disorder is most commonly observed in females as compared to males. According to the International Journal of Pharmaceutical Sciences and Research, (2018), High prevalence of varicose veins has been recorded in U.S, Europe and some parts of Australia. According to the same source, one third of the population worldwide is suffering from varicose veins, out of which, around 73% females (especially during pregnancy) and 56% males are suffering from varicose veins.

Most of the manufacturer’s headquarters are located in U.S. and Europe like QOL Medical LLC, Mckesson Corporation, Kreussler, Inc, and Teleflex Incorporated and Boston Scientific Corporation. Therefore, introduction of existing as well as new treatment options across North America and Europe is expected to drive the global microsclerotherapy treatment market growth over the forecast period.

By Region-